Format

Send to

Choose Destination
J Am Acad Dermatol. 1992 Sep;27(3):411-4.

Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders.

Author information

1
Department of Dermatology, Yokohama City University School of Medicine, Japan.

Abstract

BACKGROUND:

Adenosine deaminase (ADA) activity in serum is mainly derived from T lymphocytes.

OBJECTIVE:

Our purpose was to clarify the significance of ADA activity in systemic sclerosis (PSS) and related disorders.

METHODS:

ADA activity was determined with an enzymatic method in 34 patients with PSS, 4 with mixed connective tissue disease (MCTD), 6 with dermatomyositis (DM), 11 with localized scleroderma (LS), and 13 with other collagen diseases.

RESULTS:

Serum ADA activity was elevated over the mean (+2 standard deviations) of the control in 85% of the patients with PSS, all with MCTD, 83% of those with DM, and 82% of those with LS. The mean values in 10 PSS patients with anti-topoisomerase I antibodies, 14 patients with anti-RNP antibodies, 12 patients with anticentromere antibodies (ACAs), and 5 patients without antinuclear antibodies (ANAs) were 26.1, 24.9, 22.6, and 16.8 IU/L, respectively. In most cases, except for ACA-positive patients, serum ADA activity changed almost in parallel with ANA titers.

CONCLUSION:

These results support the notion that T cells are involved in the pathogenesis of PSS and related disorders.

PMID:
1401277
DOI:
10.1016/0190-9622(92)70209-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center